Donepezil Market 2026 expected to reach $1.3 billion by 2030 at 4.5% CAGR

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Is The Expected Market Size Of The Donepezil Market From 2026 To 2030?

The donepezil market size has shown steady expansion in recent years. It is anticipated to increase from $1.04 billion in 2025 to $1.09 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 4.5%. The historical growth can be attributed to an aging global population, the rising prevalence of alzheimer’s disease, widespread adoption of cholinesterase inhibitors, improved dementia diagnosis rates, and the expansion of neurology treatment facilities.

The donepezil market is projected to experience consistent expansion over the upcoming years, with an anticipation to reach $1.3 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 4.5%. This anticipated growth during the forecast period stems from factors such as the global rise in the elderly population, heightened awareness surrounding early dementia interventions, a growing need for affordable generic drugs, the spread of at-home cognitive support services, and increased spending on healthcare for neurodegenerative conditions. Key trends anticipated within this forecast timeframe encompass the escalating long-term application in managing Alzheimer’s disease, a rising inclination towards oral therapies for cognitive improvement, an increasing call for generic donepezil products, the broadening of treatment options for mild to moderate Alzheimer’s instances, and an amplified emphasis on neurological care for the elderly.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21174&type=smp

What Drivers Are Influencing The Donepezil Market?

The projected expansion of the donepezil market is anticipated to be driven by the rising incidence of Alzheimer’s disease. This condition, Alzheimer’s disease, is a progressive neurological ailment characterized by the deterioration and demise of brain cells, resulting in diminished memory, impaired cognitive function, and altered behaviors. The growing number of Alzheimer’s disease cases can be attributed to multiple factors, including an older demographic, overall population expansion, lifestyle choices, a rise in chronic illnesses, inherited predispositions, and environmental influences. Donepezil functions as an efficacious symptomatic treatment for Alzheimer’s disease, improving cognitive abilities and capabilities for daily activities by acting on acetylcholine concentrations within the brain. For example, in May 2024, a report from the Alzheimer’s Association, a US-based nonprofit organization focused on Alzheimer’s care, support, and research, indicated that the population of Americans aged 65 and older diagnosed with Alzheimer’s dementia increased from 6.5 million in 2022 to approximately 6.9 million in 2024. Consequently, the escalating occurrence of Alzheimer’s is fueling the expansion of the donepezil market.

Which Segments Are Included In The Analysis Of The Donepezil Market?

The donepezil market covered in this report is segmented –

1) By Type: 5mg, 10mg, 23mg

2) By Route Of Administration: Oral, Transdermal

3) By Application: Hospitals, Clinics, Drugstore

Which Trends Are Impacting The Growth Of The Donepezil Market?

Major companies in the donepezil market are prioritizing the creation of advanced drug delivery technologies, such as once-weekly and extended-release transdermal systems, with the goal of enhancing compliance and reducing discomfort from treatment in Alzheimer’s patients. A donepezil transdermal system administers the drug through the skin at a controlled rate, which bypasses first-pass metabolism and lowers the risk of gastrointestinal side effects frequently seen with oral dosing. For instance, in March 2024, Corium, Inc., a US-based biopharmaceutical company, launched its updated Adlarity formulation, featuring improved patch adhesion, enhanced skin tolerability, and a more consistent 7-day release profile that ensures uninterrupted therapeutic exposure. Corium designed this refined system to simplify Alzheimer’s care by easing the burden of dosing and boosting adherence among older adults who find daily oral medication routines challenging.

Which Key Industry Participants Are Active In The Donepezil Market?

Major companies operating in the donepezil market are AbbVie Inc., Pfizer Inc., Teva Pharmaceutical Inc., Intas Pharmaceuticals Ltd., Mylan NV, Sandoz Group AG, Hetero Drugs Ltd., Sun Pharmaceutical Inc., Eisai Co. Ltd., Cipla Ltd., Dr Reddy’s Laboratories, Apotex Inc., H Lundbeck A/S, Zydus Cadila, Amneal Pharmaceuticals LLC, Torrent Pharmaceuticals Ltd, Alkem Laboratories Ltd., Jubilant Pharmova Ltd., Wockhardt Ltd., Luoxin Pharmaceuticals Group

Read the full donepezil market report here:

https://www.thebusinessresearchcompany.com/report/donepezil-global-market-report

Which Regions Are Expected To Experience Rapid Expansion In The Donepezil Market?

North America was the largest region in the donepezil market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the donepezil market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Donepezil Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=21174&type=smp

Browse Through More Reports Similar to the Global Donepezil Market 2026, By The Business Research Company

Dozer Market Report 2026

https://www.thebusinessresearchcompany.com/report/dozer-global-market-report

Omeprazole Market Report 2026

https://www.thebusinessresearchcompany.com/report/omeprazole-global-market-report

Atenolol Market Report 2026

https://www.thebusinessresearchcompany.com/report/atenolol-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795